BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31067732)

  • 21. A Soluplus/Poloxamer 407-based self-nanoemulsifying drug delivery system for the weakly basic drug carvedilol to improve its bioavailability.
    Han H; Li Y; Peng Z; Long K; Zheng C; Wang W; Webster TJ; Ge L
    Nanomedicine; 2020 Jul; 27():102199. PubMed ID: 32275957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
    Sharma M; Sharma R; Jain DK; Saraf A
    Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fabrication, Drug Loading, and Release Behavior of Porous Mannitol.
    Li Z; Luo X; Li Q; Jin Z; Naeem A; Zhu W; Chen L; Feng Y; Ming L
    Molecules; 2024 Feb; 29(3):. PubMed ID: 38338458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous Materials as Elements of Modern Drug Delivery Systems for Anti-Inflammatory Agents: A Review of Recent Achievements.
    Moritz M; Geszke-Moritz M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatible Supramolecular Mesoporous Silica Nanoparticles as the Next-Generation Drug Delivery System.
    Mohamed F; Oo MK; Chatterjee B; Alallam B
    Front Pharmacol; 2022; 13():886981. PubMed ID: 35837281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice.
    Mamai M; Giasafaki D; Salvanou EA; Charalambopoulou G; Steriotis T; Bouziotis P
    Nanomaterials (Basel); 2021 Nov; 11(12):. PubMed ID: 34947611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles.
    Akbar N; Kawish M; Jabri T; Khan NA; Shah MR; Siddiqui R
    Pathog Glob Health; 2022 Oct; 116(7):438-454. PubMed ID: 34937524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting Food-Grade Mesoporous Silica to Preserve the Antioxidant Properties of Fresh Olive Mill Wastewaters Phenolic Extracts.
    Ianni F; Gagliardi A; Taticchi A; Servili M; Pinna N; Schoubben A; Sardella R; Bruscoli S
    Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34572992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Surface Area Mesoporous Silica Nanoparticles with Tunable Size in the Sub-Micrometer Regime: Insights on the Size and Porosity Control Mechanisms.
    Rizzi F; Castaldo R; Latronico T; Lasala P; Gentile G; Lavorgna M; Striccoli M; Agostiano A; Comparelli R; Depalo N; Curri ML; Fanizza E
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective Targeting of Colon Cancer Cells with Piperine Natural Anticancer Prodrug Using Functionalized Clusters of Hydroxyapatite Nanoparticles.
    AbouAitah K; Stefanek A; Higazy IM; Janczewska M; Swiderska-Sroda A; Chodara A; Wojnarowicz J; Szałaj U; Shahein SA; Aboul-Enein AM; Abou-Elella F; Gierlotka S; Ciach T; Lojkowski W
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31963155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
    Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
    Molecules; 2019 May; 24(9):. PubMed ID: 31067732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
    Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
    AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.